Martin E Cearnal Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Martin E Cearnal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Martin E Cearnal. Martin E Cearnal is Sr VP/Chief Commercial Officer in CUMBERLAND PHARMACEUTICALS INC ($CPIX).
Latest Insider Trading Transactions of Martin E Cearnal
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 2020 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 3.56 | 5,000 | 17,800 | 151,759 | 146.8 K to 151.8 K (+3.41 %) |
| Apr 17 2020 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 3.53 | 1,186 | 4,187 | 146,759 | 147.9 K to 146.8 K (-0.80 %) |
| Nov 29 2019 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 4.93 | 472 | 2,327 | 147,945 | 148.4 K to 147.9 K (-0.32 %) |
| Mar 22 2019 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 5.62 | 1,250 | 7,025 | 148,417 | 149.7 K to 148.4 K (-0.84 %) |
| Mar 22 2019 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 5.98 | 5,000 | 29,900 | 149,667 | 144.7 K to 149.7 K (+3.46 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 6.70 | 890 | 5,963 | 144,667 | 145.6 K to 144.7 K (-0.61 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 6.70 | 890 | 5,963 | 144,667 | 145.6 K to 144.7 K (-0.61 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.70 | 5,000 | 33,500 | 145,557 | 140.6 K to 145.6 K (+3.56 %) |
| Mar 23 2018 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.70 | 5,000 | 33,500 | 145,557 | 140.6 K to 145.6 K (+3.56 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 6.45 | 1,959 | 12,636 | 140,557 | 142.5 K to 140.6 K (-1.37 %) |
| Apr 07 2017 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.45 | 11,600 | 74,820 | 142,516 | 130.9 K to 142.5 K (+8.86 %) |
| May 27 2016 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 4.51 | 3,960 | 17,860 | 130,916 | 134.9 K to 130.9 K (-2.94 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 4.34 | 980 | 4,253 | 134,876 | 135.9 K to 134.9 K (-0.72 %) |
| Apr 08 2016 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 4.34 | 4,000 | 17,360 | 135,856 | 131.9 K to 135.9 K (+3.03 %) |
| Dec 04 2015 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 5.58 | 1,950 | 10,881 | 131,856 | 129.9 K to 131.9 K (+1.50 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Payment of Exercise | F | 6.88 | 794 | 5,463 | 129,906 | 130.7 K to 129.9 K (-0.61 %) |
| Mar 27 2015 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 6.86 | 3,000 | 20,580 | 130,700 | 127.7 K to 130.7 K (+2.35 %) |
| Mar 21 2014 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 4.58 | 3,000 | 13,740 | 127,700 | 124.7 K to 127.7 K (+2.41 %) |
| Mar 27 2013 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 4.78 | 6,000 | 28,680 | 124,700 | 118.7 K to 124.7 K (+5.05 %) |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Option Exercise | A | 0.00 | 12,128 | 0 | 12,128 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Option Exercise | D | 11.29 | 10,000 | 112,900 | 0 | |
| May 24 2012 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Option Exercise | D | 13.00 | 18,000 | 234,000 | 0 | |
| Mar 19 2012 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 7.72 | 3,000 | 23,160 | 106,572 | 103.6 K to 106.6 K (+2.90 %) |
| Mar 25 2011 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Grant | A | 0.00 | 3,000 | 0 | 103,572 | 100.6 K to 103.6 K (+2.98 %) |
| Nov 18 2010 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Option Exercise | M | 1.63 | 3,700 | 6,013 | 0 | |
| Nov 18 2010 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Option Exercise | M | 1.63 | 3,700 | 6,013 | 0 | |
| Nov 18 2010 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Buy | M | 1.63 | 7,400 | 12,025 | 100,572 | 93.2 K to 100.6 K (+7.94 %) |
| Mar 29 2010 | CPIX | CUMBERLAND PHARMAC ... | Cearnal Martin E | Sr VP/Chief Commerc ... | Option Exercise | A | 11.29 | 10,000 | 112,900 | 10,000 |
Page: 1